Postoperative pain includes all type of acute pain
that occurs due to injuries and can resolve in appropriate healing
period. Such pain often responds to analgesic medication and
treatment of the precipitating cause. Postoperative pain can also
cause cardiovascular, respiratory, endocrine, metabolic etc. The aim
of any postoperative pain treatment is to mobilize the patient as
early as possible. It allows the patient to drink and eat as early as
possible and to be able to deep breathe and cough. If patients are
not given proper postoperative pain treatment, they can have risk of
cardiac problems, chest infections, depression, wound increased
infection rate and hypoxia. Postoperative pain treatment evolved with
different understanding of how drugs affect in our body when used in
combinations.
Opioids and Non-steroidal anti-inflammatory drugs
are expected to contribute major share in terms of value to the
overall postoperative pain market. Opioids act as a substance that
acts on the opioid receptor to produce morphine like effects. They
are most often used to relieve main. Non-steroidal anti-inflammatory
drugs are used to treat pain, inflammation and fever.
Get an exclusive sample of this report :
https://www.coherentmarketinsights.com/insight/request-sample/154
Global Postoperative Pain Management
Market Taxonomy
On the basis of product type, the global market is
classified as follows:
-
Opioids
-
Fentanyl
-
Morphine
-
Meperidine
-
Others
-
Non-steroidal anti-inflammatory drugs
-
Paracetamol (acetaminophen)
-
Ibuprofen
-
Ketorolac tromethamine
-
Cyclooxygenase-2-selective inhibitors
-
Celecoxib
-
Etoricoxib
-
Rofecoxib
-
Glucocorticods
-
Local anesthetics
-
Antidepressants
-
Others
On the basis of type of pain, the global market is
classified as follows:
-
Neuropathic Pain
-
Nociceptive Pain
-
Visceral Pain
-
Somatic Pain
-
Others
On the basis of distribution channel, the global
market is classified as follows:
-
Hospital Pharmacies
-
Retail Pharmacies and Drug Store
-
E-commerce
-
Others
Prevalent Scenarios in Postoperative Pain
Management Market
Increasing number of surgical procedure is
expected to act as a value-driver to the global postoperative pain
management market. As per the World Bank, in the U.S. there were
30,537 number of surgical procedures performed in 2012. As per
National Center for Health Statistics, of overall surgical procedures
half of the procedure requires postoperative pain medication which
provides high opportunity for manufacturers. As per Centers for
Disease Control and Prevention (CDC), every year there are around 41
million visits in emergency department due to trauma. Around 450,000
burns require medical attention annually. Increase in trauma cases to
act as a fuel to the overall growth of postoperative pain management
market. Some postoperative pain drugs include side effects. Despite
the many advancement in postoperative pain management, opioids are
still considered as the mainstay pain therapy in many settings. All
opioids have significant side effects that are limiting its use. One
of the major side-effects associated with the use of opioid is
respiratory depression. According to CDC, the prescription opioid
overdose killed around 16,500 people in 2015. The increasing cases of
drug overdoses and side-effects associated with postoperative pain
drugs is expected to act as a restraint to the overall market.
Increasing geriatric population in emerging economies and increasing
prevalent cases of acute diseases is expected to fuel growth of the
market. Increasing patient awareness regarding surgeries and
operations and the growing research related to pain management is
expected to create high opportunity for pain relieving drug
manufacturers. Increasing government’s initiative to promote better
postoperative pain treatment is expected to increase growth of
market. One such initiative is APOP project (Acute postoperative pain
management), it is national multicenter quality improvement
initiative started by Australia government in 2008. The project was
aimed to improve the management of postoperative pain by promoting
the best practice. North America region is expected to contribute
major share to the overall postoperative pain management market due
to the increasing healthcare expenditure, better reimbursement
policies, easy availability of advanced healthcare treatment and
growing healthcare infrastructure in these region. Europe is expected
to be the second most lucrative market for the postoperative pain
management.
Request to view table of content @
https://www.coherentmarketinsights.com/ongoing-insight/toc/154
Highly Fragmented Market
The global postoperative pain management market is
highly fragmented, owing to the participation of many established and
emerging players. Major players involved in the market are Bayer AG,
DURECT Corporation, Pfizer Inc., BTG International Ltd, Novartis AG,
A.P. Pharma, Inc., among others.
About Coherent Market Insights:
Coherent Market Insights is a
prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations
related to emerging market trends, technologies, and potential
absolute dollar opportunity
No comments:
Post a Comment